On August 21, plant gene editing company Inari Agriculture filed an amicus brief with the U.S. Supreme Court urging it to leave in place the U.S. Court of Appeals for the Federal Circuit’s precedential decision in In re: Cellect, which relates to the application of the obviousness-type double patenting (OTDP) doctrine in the context of patent term adjustments (PTA). Inari’s amicus brief was filed the same day that the U.S. Patent and Trademark Office (USPTO) filed its brief in opposition to Cellect’s petition for writ of certiorari, arguing that the Federal Circuit was right to conclude that provisions governing PTA codified at 35 U.S.C. § 154 contemplates the application of OTDP doctrine to patents receiving PTA that are not terminally disclaimed to earlier-expiring patents claiming indistinct subject matter.
Recent Posts
- Lutnick Tells Inventors, ‘You Have a Friend’ at Commerce
- Other Barks & Bites for Friday, May 9: USPTO Responds to GAO Report; Stewart Welcomes National Inventors Hall of Fame Inductees; CAFC Defines ‘Ground’ for IPR Estoppel Statute
- PTAB Designates as Informative Stewart Decision on Discretion to Institute in Context of Parallel District Court Litigation
- Judge Hughes Again Calls Out CAFC’s Overly Rigid Article III Analysis for Pharmaceutical Cases
- Coke Stewart’s Recent Show Cause Order Offers Hope for Addressing Serial Patent Challenges